"Polyethylene Glycols" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Polymers of ETHYLENE OXIDE and water, and their ethers. They vary in consistency from liquid to solid depending on the molecular weight indicated by a number following the name. They are used as SURFACTANTS, dispersing agents, solvents, ointment and suppository bases, vehicles, and tablet excipients. Some specific groups are NONOXYNOLS, OCTOXYNOLS, and POLOXAMERS.
| Descriptor ID |
D011092
|
| MeSH Number(s) |
D02.033.455.250.700 D05.750.741 D25.720.741 J01.637.051.720.741
|
| Concept/Terms |
Polyethylene Glycols- Polyethylene Glycols
- Macrogols
- Macrogol
- Polyethylene Glycol
- Glycol, Polyethylene
- Glycols, Polyethylene
- Polyethylene Oxide
- Oxide, Polyethylene
- Oxides, Polyethylene
- Polyethylene Oxides
- Polyethyleneoxide
- Polyethyleneoxides
- Polyoxyethylenes
- Polyoxyethylene
- Tritons
|
Below are MeSH descriptors whose meaning is more general than "Polyethylene Glycols".
Below are MeSH descriptors whose meaning is more specific than "Polyethylene Glycols".
This graph shows the total number of publications written about "Polyethylene Glycols" by people in this website by year, and whether "Polyethylene Glycols" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 7 | 0 | 7 |
| 1995 | 4 | 1 | 5 |
| 1996 | 2 | 1 | 3 |
| 1997 | 2 | 1 | 3 |
| 1998 | 8 | 1 | 9 |
| 1999 | 0 | 3 | 3 |
| 2000 | 2 | 2 | 4 |
| 2001 | 6 | 1 | 7 |
| 2002 | 3 | 1 | 4 |
| 2003 | 4 | 4 | 8 |
| 2004 | 5 | 4 | 9 |
| 2005 | 8 | 4 | 12 |
| 2006 | 4 | 3 | 7 |
| 2007 | 7 | 7 | 14 |
| 2008 | 8 | 5 | 13 |
| 2009 | 3 | 7 | 10 |
| 2010 | 18 | 9 | 27 |
| 2011 | 14 | 6 | 20 |
| 2012 | 7 | 6 | 13 |
| 2013 | 8 | 3 | 11 |
| 2014 | 8 | 3 | 11 |
| 2015 | 1 | 7 | 8 |
| 2016 | 1 | 3 | 4 |
| 2017 | 3 | 5 | 8 |
| 2018 | 6 | 1 | 7 |
| 2019 | 1 | 5 | 6 |
| 2020 | 4 | 4 | 8 |
| 2021 | 2 | 3 | 5 |
| 2023 | 0 | 1 | 1 |
| 2024 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Polyethylene Glycols" by people in Profiles.
-
Pegargiminase Plus First-Line Chemotherapy in Patients With Nonepithelioid Pleural Mesothelioma: The ATOMIC-Meso Randomized Clinical Trial. JAMA Oncol. 2024 Apr 01; 10(4):475-483.
-
Highly flexible PEG-LifeAct constructs act as tunable biomimetic actin crosslinkers. Soft Matter. 2024 Jan 31; 20(5):971-977.
-
The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study. Blood Adv. 2023 01 24; 7(2):196-204.
-
Decitabine potentiates efficacy of doxorubicin in a preclinical trastuzumab-resistant HER2-positive breast cancer models. Biomed Pharmacother. 2022 Mar; 147:112662.
-
Effect of early Sanguinate (PEGylated carboxyhemoglobin bovine) infusion on cerebral blood flow to the ischemic core in experimental middle cerebral artery occlusion. J Neurointerv Surg. 2022 Dec; 14(12):1253-1257.
-
A Multifunctional Neutralizing Antibody-Conjugated Nanoparticle Inhibits and Inactivates SARS-CoV-2. Adv Sci (Weinh). 2022 01; 9(2):e2103240.
-
Levocarnitine for pegaspargase-induced hepatotoxicity in older children and young adults with acute lymphoblastic leukemia. Cancer Med. 2021 11; 10(21):7551-7560.
-
Real-world propensity score comparison of treatment effectiveness of peginterferon beta-1a vs. subcutaneous interferon beta-1a, glatiramer acetate, and teriflunomide in patients with relapsing-remitting multiple sclerosis. Mult Scler Relat Disord. 2021 Jun; 51:102935.
-
Cell-Laden Gradient Hydrogel Scaffolds for Neovascularization of Engineered Tissues. Adv Healthc Mater. 2021 04; 10(7):e2001706.
-
Perfusion-guided sonopermeation of neuroblastoma: a novel strategy for monitoring and predicting liposomal doxorubicin uptake in vivo. Theranostics. 2020; 10(18):8143-8161.